A detailed history of Telemetry Investments, L.L.C. transactions in Vaccinex, Inc. stock. As of the latest transaction made, Telemetry Investments, L.L.C. holds 416,000 shares of VCNX stock, worth $2.76 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
416,000
Previous 490,000 15.1%
Holding current value
$2.76 Million
Previous $243,000 10.29%
% of portfolio
0.42%
Previous 0.31%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$0.44 - $0.74 $32,560 - $54,760
-74,000 Reduced 15.1%
416,000 $268,000
Q3 2022

Nov 17, 2022

BUY
$0.48 - $1.2 $480 - $1,200
1,000 Added 0.2%
490,000 $243,000
Q2 2022

Aug 15, 2022

SELL
$1.05 - $1.39 $53,550 - $70,890
-51,000 Reduced 9.44%
489,000 $528,000
Q1 2022

May 16, 2022

BUY
$0.92 - $1.94 $374,440 - $789,580
407,000 Added 306.02%
540,000 $713,000
Q4 2021

Feb 14, 2022

BUY
$1.04 - $2.12 $520 - $1,060
500 Added 0.38%
133,000 $138,000
Q3 2021

Nov 15, 2021

BUY
$2.11 - $2.81 $26,375 - $35,125
12,500 Added 10.42%
132,500 $286,000
Q2 2021

Aug 16, 2021

BUY
$2.01 - $3.0 $30,149 - $45,000
15,000 Added 14.29%
120,000 $336,000
Q1 2021

May 17, 2021

BUY
$2.09 - $5.11 $60,609 - $148,190
29,000 Added 38.16%
105,000 $313,000
Q4 2020

Feb 16, 2021

BUY
$1.66 - $2.35 $29,382 - $41,595
17,700 Added 30.36%
76,000 $157,000
Q3 2020

Nov 16, 2020

BUY
$1.75 - $8.19 $102,025 - $477,477
58,300 New
58,300 $104,000
Q3 2019

Nov 14, 2019

SELL
$4.02 - $7.93 $49,043 - $96,746
-12,200 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$4.89 - $8.11 $49,643 - $82,332
-10,152 Reduced 45.42%
12,200 $67,000
Q1 2019

May 15, 2019

BUY
$3.67 - $5.5 $28,009 - $41,976
7,632 Added 51.85%
22,352 $118,000
Q4 2018

Feb 14, 2019

BUY
$3.64 - $7.12 $11,160 - $21,829
3,066 Added 26.31%
14,720 $54,000
Q3 2018

Nov 14, 2018

BUY
$6.95 - $11.64 $80,995 - $135,652
11,654 New
11,654 $85,000

Others Institutions Holding VCNX

# of Institutions
2
Shares Held
426K
Call Options Held
0
Put Options Held
0

About VACCINEX, INC.


  • Ticker VCNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,664,100
  • Market Cap $283M
  • Description
  • Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab,...
More about VCNX
Track This Portfolio

Track Telemetry Investments, L.L.C. Portfolio

Follow Telemetry Investments, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Telemetry Investments, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Telemetry Investments, L.L.C. with notifications on news.